EUTHYMICS BIOSCIENCE
Euthymics Bioscience, Inc. is a neuroscience-focused clinical-stage company developing next-generation treatments for depression. Euthymics’ initial focus is on patients who do not respond adequately to SSRIs. EB-1010 for depression is expected to improve efficacy and reduce the leading side effects associated with poor adherence to standard antidepressants including weight gain, sexual dysfunction and cognitive impairment. Euthymics is a private Delaware corporation with headquarters... in Cambridge, Massachusetts. Euthymics is developing products for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and, under a collaboration with the government, alcohol use disorder (AUD). According to the National Institutes of Health, MDD affects over 15 million American adults. According to the National Institute of Alcohol Abuse and Alcoholism (NIAAA), approximately 18 million Americans have alcohol use disorder (either alcohol dependence or alcohol abuse).
EUTHYMICS BIOSCIENCE
Social Links:
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2009-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.euthymics.com
Total Employee:
11+
Status:
Active
Contact:
617-758-0300
Email Addresses:
[email protected]
Total Funding:
38.5 M USD
Technology used in webpage:
Facebook Sharer Pinterest New Relic WhatsApp OVH Facebook Like Button Plesk Citrix NetScaler ClouDNS Kk Star Ratings
Current Advisors List
Current Employees Featured
Founder
Investors List
GBS Ventures
GBS Ventures investment in Series A - Euthymics Bioscience
H&Q Venture Capital
H&Q Venture Capital investment in Series A - Euthymics Bioscience
Novartis Venture Fund
Novartis Venture Fund investment in Series A - Euthymics Bioscience
Venture Investors
Venture Investors investment in Series A - Euthymics Bioscience
Hambrecht & Quist Capital Management
Hambrecht & Quist Capital Management investment in Series A - Euthymics Bioscience
GBS Ventures
GBS Ventures investment in Series A - Euthymics Bioscience
Novartis Venture Fund
Novartis Venture Fund investment in Series A - Euthymics Bioscience
Official Site Inspections
http://www.euthymics.com
- Host name: 172.67.180.167
- IP address: 172.67.180.167
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
